Imagine having a powerful tool at your fingertips that could increase your chances of successfully quitting smoking by nearly a third. A recent study has unveiled that mobile chat messaging, which connects users with both a counselor and a helpful chatbot, can significantly support individuals in their journey to stop smoking. This compelling research was published today in the esteemed journal JAMA Internal Medicine, shedding light on an innovative approach to smoking cessation.
The study investigated nearly 600 individuals who were daily smokers and had managed to abstain for a period ranging from three to thirty days. These participants were enrolled in smoking cessation programs at clinics located in Hong Kong. To better understand the effectiveness of mobile support, the researchers divided the participants into two groups.
One half received comprehensive chat-based assistance, which included interaction with a live counselor through a messaging app, alongside access to a supportive chatbot for a duration of three months. In contrast, the control group only received eight text messages over the same period, containing generic advice on how to quit smoking—far less personalized and engaging.
All participants, regardless of the group they were assigned to, continued to receive standard smoking cessation treatment provided by the clinics. After a six-month follow-up, the outcomes revealed a notable difference between the two groups. Those who had access to the counselor and chatbot support exhibited a higher rate of long-term abstinence; specifically, 46% of this intervention group managed to remain smoke-free, compared to only 36% in the control group.
Additionally, the intervention group experienced a lower rate of relapse, indicating that the support offered through mobile chat can be a game-changer for those attempting to quit smoking. The researchers emphasized, "This randomized clinical trial demonstrated that mobile chat messaging for preventing smoking relapse resulted in an approximate 30% increase in validated abstinence, presenting a scalable solution to maintain sobriety among individuals who have recently quit smoking."
For those eager to delve deeper into the research findings, the complete study is available here.
In the latest issue of Pharmacy Daily released on January 21, 2026, this insightful article reached subscribers eager for updates on health-related news.
Curious about other recent developments? Here are some headlines that caught attention:
- Priceline responds to controversy: In an open letter addressed to franchisees, Richard Pearson, Priceline Pharmacy's chief customer officer, has refuted some "inaccurate" media reports surrounding the administration of Infinity last year.
- Safety alerts regarding andrographis: An updated safety review is currently in progress for Andrographis paniculata, a herbal medicine ingredient, as incidents of anaphylaxis and severe allergic reactions continue to surface.
So, what do you think about the role of technology in smoking cessation? Could mobile chat support be the key to helping more people quit? Share your thoughts and experiences in the comments!
